UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Archford Capital Strategies LLC

Archford Capital Strategies LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,788 shares of the healthcare conglomerate’s stock after purchasing an additional 256 shares during the quarter. Archford Capital Strategies LLC’s holdings in UnitedHealth Group were worth $1,480,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Anfield Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth $26,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of UnitedHealth Group during the second quarter worth $28,000. Activest Wealth Management acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $29,000. Finally, Ten Capital Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 111.6% in the 2nd quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 48 shares during the period. Hedge funds and other institutional investors own 86.20% of the company’s stock.

In related news, Director Stephen J. Hemsley sold 75,000 shares of the firm’s stock in a transaction that occurred on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the transaction, the director now directly owns 154,403 shares in the company, valued at approximately $64,347,450.25. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 82,500 shares of company stock valued at $36,855,125. 0.55% of the stock is currently owned by corporate insiders.

UNH has been the topic of a number of analyst reports. SVB Leerink initiated coverage on shares of UnitedHealth Group in a report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective on the stock. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective on the stock in a report on Wednesday, October 27th. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $473.00 to $476.00 and gave the stock an “outperform” rating in a report on Friday, October 15th. Mizuho raised their target price on shares of UnitedHealth Group from $455.00 to $500.00 and gave the company a “buy” rating in a research note on Wednesday, November 10th. Finally, Cowen began coverage on shares of UnitedHealth Group in a research note on Thursday, September 9th. They set an “outperform” rating and a $478.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $477.35.

NYSE:UNH opened at $450.16 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $320.35 and a twelve month high of $466.00. The company has a 50-day moving average of $430.47 and a 200-day moving average of $418.01. The firm has a market cap of $423.98 billion, a price-to-earnings ratio of 27.93, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The company had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. During the same period last year, the company posted $3.51 earnings per share. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be issued a $1.45 dividend. This represents a $5.80 annualized dividend and a dividend yield of 1.29%. The ex-dividend date is Friday, December 3rd. UnitedHealth Group’s payout ratio is 35.98%.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Further Reading: What are momentum indicators and what do they show?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.